Sentences with phrase «vaccine designed by»

Not exact matches

Flu vaccines are designed to prevent infection by eliciting antibodies against HA, which the virus uses to break into cells lining the airways.

These findings improve understanding of the mechanisms that make flu outbreaks so difficult to prevent, and inform efforts to design more effective flu vaccines that are less easily thwarted by continual mutation.

The HPV vaccine - specific educational brochure, designed to motivate parents to start the series, had mixed results by race / ethnicity.

Scientists say that the new design may eliminate the problems with the failed 2002 vaccine (manufactured by Elan Corporation, an Ireland - based drug company).

By better understanding how antigen presentation is translated into long - term immunity, immunologists can inform the design of simpler vaccines.

But this information is vital for scientists who are trying to design vaccines to protect against sexual transmission because inside cells, the virus may go undetected by the immune system.

Equipped with this deeper understanding, researchers are trying to make allergy vaccines safer and more effective by designing them to micromanage the allergic immune response.

By customizing the RNA sequences, the researchers can design vaccines that produce nearly any protein they want.

The vaccine is designed to be delivered by intramuscular injection, making it easy to administer.

According to Malo, «public health interventions designed to increase HPV vaccine recommendation for males should focus on increasing recommendations by family practitioners and also identifying and supporting innovators and early adopters who may help diffuse HPV vaccination guidelines and encourage later adopters to support the recommendations.»

«This helps us understand that process, and it opens up the window to targeting these cells by designing vaccines that prevent autoimmunity.»

«Our vaccine was made possible by combining a wide range of biomedical expertise that thrives in Boston and Cambridge,» said Mooney, who specializes in the design of biomaterials for tissue engineering and drug delivery.

Led by University of Texas Austin researcher Dr Steve Bellan, and in collaboration with the U.S. Centers for Disease Control and Prevention (CDC), the study on the design of CDC's vaccine trial in Sierra Leone is published in The Lancet Infectious Diseases.

«Uncovering the process by which neutralizing antibodies develop is critical to HIV vaccine design,» said Elise Landais, Senior Research Scientist with IAVI and lead author of the study.

Inspired by the earlier work, Deborah Fuller from the University of Washington in Seattle, USA, who is interested in developing influenza drugs and vaccines, teamed up with David Baker, also at the University of Washington, who is an expert in computational protein design.

«This will allow us to design better inhibitors or vaccines that block invasion by targeting multiple steps at the same time.»

Led by scientists at the International AIDS Vaccine Initiative (IAVI) and The Scripps Research Institute (TSRI), the results offer important insight into a potential AIDS vaccine Vaccine Initiative (IAVI) and The Scripps Research Institute (TSRI), the results offer important insight into a potential AIDS vaccine vaccine design.

«This is good news for vaccine design,» says O'Connor, whose work is funded by the National Institutes of Health.

Historically, many vaccines have been designed to evoke an antibody response by B cells following innoculation with weakened or dead pathogens.

More to the point, by genetically stripping dengue virus of its ability to bind 14 -3-3 epsilon, Gack has generated a crippled virus that can elicit a strong human immune response, providing a framework for rational vaccine design against emerging infectious diseases.

More importantly, Gack found that avian, swine, and human flu viruses block TRIM25 to evade immune defense by RIG - I, unraveling a molecular target for the design of antiviral drugs and vaccines.

This approach will also elucidate mechanisms of anti-body mediated protection from infection by HIV - that are highly likely to inform vaccine design.

Historically, many vaccines have been designed to evoke an antibody response by B cells following inoculation with weakened or dead pathogens.

We also carry a product called «VacciShield,» an evidence - based supplement designed by a naturopathic physician for the purpose of reducing vaccine reactions.

With a new properly designed facility, our vaccine clinics could essentially double by providing 30,000 affordable vaccinations each year — which will keep pets healthy and compliant with the law.

Zoetis discovers, develops and manufactures a diverse portfolio of animal health medicines and vaccines, complemented by diagnostic products, genetic tests, biodevices and a range of services, which are designed to meet the real - world needs of veterinarians and the livestock farmers and companion animal owners they support.

Animal Friends» Clinic Services Program consists of three core components each uniquely designed to support a targeted population by offering pets high - quality, low - cost spay / neuter, vaccines and wellness services.

A vaccine is designed to trigger an immune response within the pet's immune system to help the body to recognize and appropriately respond to future infections caused by disease.

Thankfully there is a vaccine, which we carry, designed to protect against disease caused by the CIV H3N2 strain.

VANGUARD ® crLyme is a multivalent vaccine which contains an OspA protein and a single OspC protein that is composed of antigenic material from seven common types of OspC found in Lyme - infected dogs in the U.S. 1 Its uniquely targeted design helps provide a broad spectrum of coverage while delivering a low - reactive vaccine by minimizing the amount of extraneous proteins administered to the dog.

About Vanguard crLyme Vanguard crLyme is a next - generation multivalent vaccine which contains outer surface protein A (OspA) protein and a single OspC protein that is composed of antigenic material from seven common types of OspC found in Lyme - infected dogs in the U.S. 1 Its uniquely targeted design helps provide a broad spectrum of coverage while delivering a low - reactive vaccine by minimizing the amount of extraneous proteins administered to the dog.

Guided by the Behavioral Vaccine Theory of prevention, this study uses a no - control group design to examine intervention variables that predict favorable changes in depressive symptoms at the six - to - eight week follow - up in at - risk adolescents who participated in a primary care, Internet - based prevention program.